Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Belchertown › NPI 1144819053
NP / PA

Behrens, Abigail

Behrens, Abigail was paid $55K by Medicaid between Jan 2023 and Feb 2024, across 3 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.

33Billing provider infoBEHRENS, ABIGAIL
BELCHERTOWN, MA 01007
33aNPI1144819053assigned 01/14/2021
33bProvider typePhysician Assistant
28Total paid$55K
24GClaims948
24DCodes billed3
24AFirst – last monthJan 2023 – Feb 2024
Compared with peers

Next to other Physician Assistant providers in Massachusetts

Rank by total paid#47 of 272
Median peer was paid$6K
This provider vs. median8.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.5K$5.0K$7.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2023844$48K
2024incomplete104$7K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 56% 413 247 $31K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 42% 518 311 $23K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.8% 17 14 $977.93

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.